ProfileGDS5678 / 1422003_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 20% 19% 20% 20% 19% 19% 19% 20% 19% 20% 22% 20% 20% 20% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4954520
GSM967853U87-EV human glioblastoma xenograft - Control 22.4626919
GSM967854U87-EV human glioblastoma xenograft - Control 32.4796720
GSM967855U87-EV human glioblastoma xenograft - Control 42.4250120
GSM967856U87-EV human glioblastoma xenograft - Control 52.4202919
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.5253819
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.485619
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4544420
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.4355919
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4649720
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.5015522
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.4495620
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.4695820
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.4674320